Trial Profile
G-Pen (Glucagon Injection) for Induced Hypoglycemia Rescue in Adult Patients With T1D
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- Sponsors XERIS Pharmaceuticals
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 16 Jun 2017 According to a Xeris Pharmaceuticals media release, results were presented at the 77th Scientific Session of the American Diabetes Association (ADA)
- 16 Jun 2017 Results published in a Xeris Pharmaceuticals media release.